Braster
Braster S.A. is a Polish publicly traded MedTech (WSE: BRS) that builds liquid crystal contact thermography devices — the consumer Braster System and the clinical Braster Pro — paired with AI-driven telemedical analysis for early breast cancer screening, sold direct-to-consumer and through certified clinics across more than 22 international markets.
- Company typePublic
- Founded2007
- HeadquartersOzarow Mazowiecki, Poland
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Braster does
Braster S.A. is a publicly listed Polish medical technology company (WSE: BRS, IPO June 2015) that develops and commercializes liquid crystal contact thermography (CLCF) devices for breast health screening. Its portfolio comprises the Braster System, a consumer device sold direct-to-consumer in Poland and the Netherlands at 1,799-2,798 PLN (390-600 EUR), and Braster Pro, a professional unit sold to gynecologists and clinics at ~2,799-2,999 PLN; the company operates an 80+ certified Pro clinic network in Poland. Thermographic images captured by the devices are uploaded via the Braster Care mobile app to a telemedical center where AI algorithms (co-developed with Warsaw University of Technology and supported by an EU grant of ~5.1M PLN) perform two-method asymmetry and longitudinal differential analysis, with results returned in approximately two working days.
The company monetizes through a mix of one-time device hardware sales (System, Pro, replacement matrix sets), recurring examination credit packages (6/12/24/50/100 credits valid 7-26 months), accessories, and B2B distribution via national partners in markets including Hungary, Ukraine, the UK, Bulgaria, Korea, and the Balkans, plus corporate wellness deployments such as Santander Consumer Bank. Braster is CE-marked (Council Directive 93/42/EEC), ISO 13485 and ISO 9001 certified (TÜV NORD), and has formal recognition from the Polish Society of Gynecologists and Obstetricians as a complementary examination to mammography or ultrasound.
Clinically, Braster cites 81.5% sensitivity and 87% specificity in women under 50 (TheraALG study), 82% efficacy detecting changes smaller than 2 cm, and a detection threshold from 3 mm, supported by observational studies across more than 4,600 women in collaboration with Collegium Medicum of Jagiellonian University, Military Institute of Medicine, and other Polish oncology centers. R&D, manufacturing partnerships (Creotech, ROSTI Sweden, Pezy Netherlands), and product marketing are coordinated from its headquarters in Ożarów Mazowiecki, Poland, with the underlying technology protected as proprietary inventions and brand identity.
Braster firmographics
Firmographics- Name
- Braster
- Legal name
- BRASTER S.A.
- Website
- https://braster.eu
- Company type
- Public
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Braster S.A. is a Polish publicly traded MedTech (WSE: BRS) that builds liquid crystal contact thermography devices — the consumer Braster System and the clinical Braster Pro — paired with AI-driven telemedical analysis for early breast cancer screening, sold direct-to-consumer and through certified clinics across more than 22 international markets.
- Ownership category
- akta.pro rank
Braster industry classification
Industry- Product category
- Medical Devices for Breast Cancer Screening
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Mammography & Breast Imaging Systems (HLAHABAF)
- akta.pro secondary industries
- Continuous Temperature & Fever Monitoring (Wearable Thermometry) (HLAHACAK), Women’s Health & Fertility Tracking Devices (Ovulation/Temp Sensors, Pelvic Health Devices) (CRACAQAJ)
Keywords
Where Braster is headquartered
LocationHeadquarters
- HQ city
- Ozarow Mazowiecki
- HQ country
- Poland
- HQ region
- Europe
Offices2 records
Markets served
Braster business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Device Sales (Braster System): One-time sale of the Braster medical device for home breast examination. Includes device hardware, 3 matrices, and initial examination package. Purchased directly through e-commerce store.
- Examination Packages: Recurring revenue from examination package subscriptions. Customers purchase examination credits (6, 12, 24, 50, or 100 exams) that expire within specified periods (7-26 months). Includes access to Braster Care app and telemedical analysis.
- Braster Pro Professional Device Sales: Sale of Braster Pro medical devices to healthcare professionals and clinics, including device, matrices, and initial examination package. Targeted at gynecological and medical offices.
- Accessories and Replacement Matrices: Sale of replacement matrix sets (3 matrices per set) and other accessories. Matrices have approximately 3-year lifespan and require replacement.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Braster System - Home use device with 4 free examinations |
| One time/ perpetual license | Multi-year contract | Braster Duo - Device for two people with 6 free examinations |
| One time/ perpetual license | Multi-year contract | Braster Pro Basic - Professional device with 50 free examinations |
| One time/ perpetual license | Multi-year contract | Braster Pro Professional - Professional device with enhanced features |
| Subscription | Multi-year contract | 6-Examination Package |
| Subscription | Multi-year contract | 12-Examination Package |
| Subscription | Multi-year contract | 24-Examination Package |
| Subscription | Multi-year contract | 50-Examination Package (Professional) |
| Subscription | Multi-year contract | 100-Examination Package (Professional) |
| Unit Pricing | Multi-year contract | Set of 3 Replacement Matrices |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels9 records
Braster product offering
Product offeringCore offering
Braster develops and sells medical devices for breast cancer screening based on proprietary liquid crystal contact thermography technology. The portfolio includes the Braster System for at-home monthly self-examination, the Braster Pro for use by healthcare professionals in clinical settings, and a Temperature Indicator for fever screening. Each device is paired with the Braster Care mobile app and remote AI-powered telemedical analysis that delivers examination results within 2 working days.
Product overview
Braster offers a portfolio of breast health monitoring products centered on liquid crystal contact thermography technology. The core offerings include Braster System for home use and Braster Pro for professional clinical settings, both utilizing proprietary AI-powered algorithms to detect thermal and structural asymmetries in breast tissue. Braster System is a consumer-facing product combining a handheld medical device, the Braster Care smartphone app, and telemedical center analysis services for monthly self-examinations. Braster Pro adapts this technology for healthcare professionals in medical clinics. Additional products include examination credit packages, replacement matrix sets, and the Temperature Indicator for general fever screening.
Differentiator
Problem solved
Functional benefit
Brands
- Braster System: In-home breast examination system using contact thermography with telemedicine support for monthly self-examinations
- Braster Pro
Products and services
- Braster System In-home breast examination system for individual women. Includes the Braster handheld medical device (wireless, portable, radiation-free), a set of 3 liquid crystal matrices, the Braster Care mobile app, and AI-powered telemedical analysis delivered within 2 working days for monthly self-examination.
- Braster Pro Professional breast examination system for healthcare professionals (gynecologists, oncologists, clinics). Uses the same liquid crystal contact thermography technology with AI-powered automated interpretation to support early breast cancer diagnosis during standard patient visits.
- Braster Start Consumer bundle of the Braster System — the Braster medical device plus a set of 3 liquid crystal matrices and 4 free examination credits usable within 7 months of activation. Targeted at individual first-time users.
- Braster Duo Braster system package for two users sharing a single device — includes the Braster device, an extra set of 3 matrices, and two packages of 3 examination credits each, with separate user accounts.
- Temperature Indicator Self-adhesive thermosensitive foil device applied to the forehead for non-contact fever screening, using Braster's liquid crystal technology. Targeted at medical staff, care-facility patients, and office or factory employee screening.
- Examination Packages Recurring examination credit packages available in 6, 12, 24, 50, and 100 examination sizes with validity periods ranging from 7 to 26 months from activation. Each credit enables one breast thermography examination analyzed by the Brasster Telemedical Center, with access to the Braster Care app.
- Set of 3 Replacement Matrices Replacement liquid crystal matrix set (3 matrices per set) for the Braster device. Each matrix has different thermal sensitivity ranges matched to different breast temperature ranges; matrices have a lifespan of approximately 3 years and must be replaced thereafter.
Quantifiable outcome
- 81.5% sensitivity and 87% specificity in women under 50 (ThermaALG study)
- +3 more outcomes
Companies that use Braster
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles4 records
Braster technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
Braster partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor and core.
- Hungarian DistributorminorDistribution agreement for Hungarian market as part of international expansion strategy.
- Ukrainian DistributorminorDistribution agreement for Ukrainian market as part of international expansion strategy.
- Santander Consumer BankminorCorporate wellness partnership where Santander Consumer Bank employees can check their breast health monthly using Braster System as part of employee health benefits program.
- ROSTI (Sweden)coreSwedish manufacturing partner for production of Braster medical devices. Partnership established to launch manufacturing of the medical device for commercial distribution.
- Pezy (Netherlands)coreDutch design partner that helped prepare the consumer version of the Braster device for market launch. Collaboration on product design and user experience.
- CreotechcoreManufacturing partnership for new generation thermographic image registering heads used in observational clinical studies. Creotech manufactures specialized equipment for Braster's research and development activities.
- Warsaw University of TechnologycoreAcademic partnership for development of automatic interpretation system for thermographic images and differential analysis algorithms. Joint research on optimizing AI systems for breast cancer detection.
- Maiczin Dom Hospital (Sofia, Bulgaria)coreDesignated as BRASTER Reference Center for Balkan countries. Hospital serves as hub for Braster Pro distribution and training in the region.
- Innomed Research NetworkcoreMulticenter observational study involving approximately 3000 women conducted by Collegium Medicum of Jagiellonian University in cooperation with multiple oncology centers across Poland.
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
Braster competitors and assessment
Company assessmentBroad incumbents
- Hologic: Global leader in mammography and breast health imaging (3Dimensions, Genius AI CAD). Comparable as a dominant breast-cancer screening device manufacturer; Braster is the smaller, complementary thermography entrant addressing intervals between Hologic's core mammography exams.
- Siemens Healthineers: Major breast imaging player (MAMMOMAT tomosynthesis, AI-Rad Companion). Comparable as a large incumbent in clinical breast cancer detection whose installed mammography base defines the screening workflow Braster plugs into between visits.
- GE HealthCare: Mammography and women's health imaging provider (Pristina, Invenia ABUS). Comparable as a broad clinical incumbent whose screening platform competes with — and channels patients toward — Braster's complementary monitoring device.
- Philips Healthcare: Wide-portfolio women's health and patient monitoring vendor (MicroDose mammography). Comparable as a multi-modality incumbent whose clinical scale and channel relationships Braster must navigate to win clinic placements.
- Samsung Medison (Samsung Healthcare): Women's imaging/ultrasound vendor with growing breast imaging product line. Comparable as a broad imaging incumbent whose handheld/portable ultrasound strategy parallels Braster's positioning of portable, clinic-friendly diagnostic tools.
Emerging players
- iCAD, Inc. AI-based breast cancer detection and risk prediction vendor (ProFound AI). Comparable as a breast-AI software-focused company; Braster pairs analogous AI interpretation with a thermal-imaging sensor, making both complementary rather than direct competitors.
- Volpara Health Technologies: AI-based breast density and risk assessment platform. Comparable as a specialized breast-imaging analytics company serving clinics and consumers; Braster competes for clinical mindshare around adjunctive breast screening.
- ScreenPoint Medical: Developer of AI for mammography (Transpara). Comparable as a software-led breast imaging AI peer building decision-support tools that clinicians layer onto screening workflows, similar to Braster's Telemedical AI analysis.
Direct peers
- Realtherm / Infrared Sciences Corp: Specialist in infrared/thermal breast imaging for clinical screening. Comparable as a direct thermography-based breast screening peer addressing the same niche market position Braster occupies.
Regional players
- Thermography.com / Med-Hot Thermal Imaging: US-based clinical thermal imaging service providers that perform breast thermography screening in clinical settings. Comparable as breast-thermography service providers operating in adjacent geographies, illustrating the regional competitive set Braster must differentiate against in-market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Braster social profiles
Digital presenceBraster compliance and trust
Trust signalCompliance4 records
Braster financial estimates
Financial estimateRevenue estimate
Valuation estimate
Braster leadership team
Management profileNumber of profiles
Profiles8 records
Braster funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Braster M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Braster
What does Braster do?
Braster develops and sells medical devices for breast cancer screening based on proprietary liquid crystal contact thermography technology. The portfolio includes the Braster System for at-home monthly self-examination, the Braster Pro for use by healthcare professionals in clinical settings, and a Temperature Indicator for fever screening. Each device is paired with the Braster Care mobile app and remote AI-powered telemedical analysis that delivers examination results within 2 working days.
Is Braster a public or private company?
Braster is a public company. It is classified as public and is currently operating.
When was Braster founded?
Braster was founded in 2007. It employs 11 to 50 people.
Where is Braster based?
Braster is headquartered in Ozarow Mazowiecki, Poland, in the Europe region.
How does Braster make money?
Four revenue lines are on record. Medical Device Sales (Braster System) is the primary driver. The others are examination Packages, braster Pro Professional Device Sales and accessories and Replacement Matrices.
Who are Braster's main competitors?
Broad incumbents on record are Hologic, Siemens Healthineers, GE HealthCare, Philips Healthcare and Samsung Medison (Samsung Healthcare). Emerging players are iCAD, Inc., Volpara Health Technologies and ScreenPoint Medical. Realtherm / Infrared Sciences Corp is listed as a direct peer. Thermography.com / Med-Hot Thermal Imaging is listed as a regional player.
Does Braster have an API?
No public API is recorded for Braster.
What industry is Braster in?
Braster's product category is Medical Devices for Breast Cancer Screening. Its primary akta.pro industry code is HLAHABAF, Mammography & Breast Imaging Systems, with a secondary code of HLAHACAK, Continuous Temperature & Fever Monitoring (Wearable Thermometry). Its NAICS code is 334510 and its SIC code is 3845.